The Future Trends Of Molecular Diagnostics

By Author: Bio Dot
Total Articles: 1
Comment this article

Molecular diagnostics includes all tests and methods to identify a disease or the predisposition for a disease analyzing DNA or RNA of an organism. They are utilized to identify infectious diseases like chlamydia, gonorrhea, influenza virus and tuberculosis as well as the presence or predisposition to different conditions ranging from cancer to cystic fibrosis.

The main function of DNA is to encode your genetic information and potential details of disease. Molecular diagnostics evaluates your biological composition at the genetic level. The process of unlocking DNA code can divulge variations among individuals that can symbolize a predisposition towards development of particular disease. It can reveal vital treatment alternatives that can prove to be more effective in some people.

The prime functions of molecular diagnostic tests are to evaluate genetic content for disease information. These tests can be carried out in a series of detailed regions of DNA to discover genetic mutations or quantify the levels of certain genetic materials that can be expressed as a bacterium, virus or cancer. Your ability to respond ...
... to a particular treatment depends on the probability of developing a disease and your DNA sequence that may consist of an inherited or random mutation. The significant molecular diagnostic is competent at identifying even specific strains of infections like H1N1 virus.

The most imperative benefits of identifying the genetic predisposition for a particular disease or health condition alerts an individual to make certain lifestyle changes and choices. Moreover the advantages extend at keeping the patient away from disease and further help them in monitoring the development of the meticulous disease.

Molecular diagnostic technologies provide the potential for moving from diagnostics to prognostics. The market for molecular diagnostic is intricate guesswork, as it coincides with the in vitro diagnostic market and is less definite than the pharmaceutical or other device markets. But now in the post era of accomplishing the “Human Genome Project”, molecular diagnostics is prepared to get its real due as the legitimate future business juncture in healthcare industry. The need for molecular diagnostic test will be mandatory for every gene based therapeutic test and thus stimulate the diagnostic marketplace. An estimated of numerous infectious disease testing and blood banking applications is expected. In years to come applications for pharmacogenetic, predisposition diagnostics and molecular cancer diagnostics will follow.

The molecular technologies present significant revenue potential, non-invasive or minimal-invasive procedures, instant diagnostic results, more targeted therapies and shorter hospitalization times. Additionally molecular diagnostics will help to decrease cost for diagnosis, therapy and healthcare altogether.